Investment Thesis
Humana exhibits solid balance sheet fundamentals and positive cash generation, but faces significant profitability headwinds with declining net income and EPS despite exceptional revenue growth that appears acquisition-driven. The 2122.9% revenue spike without corresponding earnings growth raises concerns about integration challenges and margin compression in core operations.
Strengths
- Strong liquidity position with $5.0B cash and 1.77x current ratio supports operational flexibility
- Healthy free cash flow of $1.1B and positive operating cash flow demonstrate underlying business cash generation
- Moderate leverage (0.66x debt/equity) and strong 11.0x interest coverage provide financial stability
Risks
- Declining net income (-1.2% YoY) and EPS (-1.4% YoY) despite massive revenue increase suggests acquisition integration challenges or margin deterioration
- Very low net margin (3.0%) and operating margin (4.4%) indicate tight profitability with limited operational cushion
- Poor capital efficiency reflected in ROE of 6.4% and ROA of 2.1% below industry standards
Key Metrics to Watch
- Operating and net margin trends to assess if profitability stabilizes post-integration
- Year-over-year organic revenue growth excluding acquisition effects
- Return on equity trajectory and capital deployment efficiency in coming quarters
Financial Metrics
Revenue
39.6B
Net Income
1.2B
EPS (Diluted)
$9.83
Free Cash Flow
1.1B
Total Assets
55.3B
Cash
5.0B
Profitability Ratios
Gross Margin
N/A
Operating Margin
4.4%
Net Margin
3.0%
ROE
6.4%
ROA
2.1%
FCF Margin
2.9%
Balance Sheet & Liquidity
Current Ratio
1.77x
Quick Ratio
1.77x
Debt/Equity
0.66x
Debt/Assets
66.3%
Interest Coverage
11.03x
Long-term Debt
12.3B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-06T15:25:02.194026 |
Data as of: 2026-03-31 |
Powered by Claude AI